About R3 Vascular
R3 Vascular is a private company based in Mountain View, California. It has reported $75,167,698 raised in two offerings on Form D since May 2020. Its chief executive is Christopher Owens.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | Sep 12, 2024 | $72,499,781target not set | 34 | $2.1M | EquityRule 506(b) | Form D ↗ |
| Aug 14, 2019 | May 18, 2020 | $2,667,917of $3.0M target | 23 | $115K | DebtRule 504, Rule 506(c) | Form D ↗ |
| Total, two offerings | $75,167,698 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on R3 Vascular's Form D filed Sep 12, 2024.
KR
Kamal Ramzipoor
CTO, Founder
FG
Frederik Groenewegen
Director
JS
John Springer
Director
MH
DN
David Neustaedter
Director
CO
Christopher Owens
President and Chief Executive Officer, director
Amir Abolfathi
Director
Also a director at BRIUS, an executive chairman at MaxQ Medical and an independent board member at Ventaris Surgical.
NH
Nathan Harrington
Director
Earlier filings also listed Mahmood Razavi (director, last listed May 2020) and JeanMarie Markham (director, last listed May 2020).